ARCHIVES

Zelboraf Increased Overall Survival To 15.9 Months in Phase II Study

This article is from The Cancer Letter archive.

Vol. 35 No. 3 | March 30, 2012

Download PDF Visit The Full Archive

Related Articles

Paul Goss, Patricia Ganz Discuss Breast Cancer Prevention Trials.

April 20, 2007

Early-Stage HER2+ Breast Cancer Patients Are At Significant Risk Of Recurrence

December 26, 2008

In Brief: Mauer to Leave St. Jude For U. Tennessee As Cancer Program Director; Harvard, MIT Share ACS Award

July 29, 1983

ACS-Roosevelt Awards Go to 19 New Fellows

July 30, 1976

In Brief: Emory Univ. Receives $295 Million Endowment; Winship Cancer Center To Get Half of Income

August 16, 1996

Award Fees Show House NCI thinks FCRF Contractors Are Performing

August 15, 1986